How Focusing On Obscure Diseases Made BioMarin A $15 Billion Company

July 28, 2016 | BioMarin became one of the world's most valuable biotechs by jettisoning costly distractions and focusing on one thing: treating some of the rarest diseases on the planet. Forbes